Allogene Therapeutics Inc... (ALLO)
NASDAQ: ALLO
· Real-Time Price · USD
1.11
0.04 (3.74%)
At close: Aug 15, 2025, 12:13 PM
Allogene Therapeutics Revenue
Allogene Therapeutics reported an annual revenue of $22K, reflecting a -76.84% growth. For the quarter ending June 30, 2025, Allogene Therapeutics generated $0 in revenue.
Revenue (ttm)
22K
Revenue Growth
-76.84%
Price / Sales Ratio
18861.34
Revenue / Employee
97.35
Employees
226
Market Cap
243.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|